XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Beginning balance, value at Dec. 31, 2021 $ (93,621) $ 9 $ 957,730 $ (1,051,360)
Beginning balance, shares at Dec. 31, 2021   8,598,000    
Shares issued for vested restricted stock units and warrants (in shares)   71,000    
Share-based compensation 2,062   2,062  
Net loss (49,021)     (49,021)
Ending balance, value at Mar. 31, 2022 (140,580) $ 9 959,792 (1,100,381)
Ending balance, shares at Mar. 31, 2022   8,669,000    
Beginning balance, value at Dec. 31, 2021 (93,621) $ 9 957,730 (1,051,360)
Beginning balance, shares at Dec. 31, 2021   8,598,000    
Net loss 63,260      
Ending balance, value at Jun. 30, 2022 (26,066) $ 9 962,025 (988,100)
Ending balance, shares at Jun. 30, 2022   8,860,000    
Beginning balance, value at Mar. 31, 2022 (140,580) $ 9 959,792 (1,100,381)
Beginning balance, shares at Mar. 31, 2022   8,669,000    
Shares issued for vested restricted stock units and warrants (in shares)   44,000    
Share-based compensation 2,219   2,219  
Shares issued for rounding up of fractional shares in connection with the reverse stock split   142,000    
Shares issued for sale of common stock related to employee stock purchase plan 14   14  
Shares issued for sale of common stock related to employee stock purchase plan (in shares)   5,000    
Net loss 112,281     112,281
Ending balance, value at Jun. 30, 2022 (26,066) $ 9 962,025 (988,100)
Ending balance, shares at Jun. 30, 2022   8,860,000    
Beginning balance, value at Dec. 31, 2022 $ 35,143 $ 9 974,497 (939,363)
Beginning balance, shares at Dec. 31, 2022 9,498,000 9,498,000    
Shares issued for vested restricted stock units and warrants (in shares)   455,000    
Shares issued for vested restricted stock units and warrants $ 1 $ 1    
Share-based compensation 483   483  
Net loss (3,603)     (3,603)
Ending balance, value at Mar. 31, 2023 32,024 $ 10 974,980 (942,966)
Ending balance, shares at Mar. 31, 2023   9,953,000    
Beginning balance, value at Dec. 31, 2022 $ 35,143 $ 9 974,497 (939,363)
Beginning balance, shares at Dec. 31, 2022 9,498,000 9,498,000    
Net loss $ (6,017)      
Ending balance, value at Jun. 30, 2023 $ 31,197 $ 11 976,566 (945,380)
Ending balance, shares at Jun. 30, 2023 10,575,000 10,575,000    
Beginning balance, value at Mar. 31, 2023 $ 32,024 $ 10 974,980 (942,966)
Beginning balance, shares at Mar. 31, 2023   9,953,000    
Shares issued for sale of common stock related to private placement sale (in shares)   313,000    
Shares issued for vested restricted stock units and warrants (in shares)   309    
Share-based compensation (in share)   0    
Share-based compensation 437   437  
Shares issued for sale of common stock related to private placement sale 1,150 $ 1 1,149  
Net loss (2,414)     (2,414)
Ending balance, value at Jun. 30, 2023 $ 31,197 $ 11 $ 976,566 $ (945,380)
Ending balance, shares at Jun. 30, 2023 10,575,000 10,575,000